Inari Medical, Inc. (NARI) Misses Q4 EPS by 9c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts NARI Hot Sheet
Join SI Premium – FREE
Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of ($0.08), $0.09 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $132.1 million versus the consensus estimate of $131.76 million.
For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASM International posts Q3 net income of €308.1m, raises 2027 revenue target
- Corning shares rise 3% in premarket trade after Q3 EPS, revenue beat estimates
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
